Researching Posttraumatic Headache With Cranial Neuralgias: Paul G. Mathew, MD, DNBPAS, FAAN, FAHS
July 27th 2021The assistant professor of neurology at Harvard Medical School discussed the motivation behind uncovering more about painful cranial neuralgias and their association with posttraumatic headache.
Sildenafil Shows Potential as Alzheimer Disease Preventive Therapy
July 27th 2021The therapy, already FDA-approved for individuals with pulmonary artery disease, was significantly associated with reduced likelihood of Alzheimer disease in both the 65-74 year range and those older than 75 years.
Stroke Systems of Care: Mitchell S.V. Elkind, MD, MS, MPhil
July 26th 2021Following the publication of new guidelines for the care of adults poststroke, the president of the American Heart Association commented on streamlining systems of care to manage acute stroke and foster long-term prevention.
Research in Alzheimer Disease and Dementia: Jessica Zwerling, MD, MS
July 25th 2021The director of Montefiore Hudson Valley Center of Excellence for Alzheimer’s Disease, associate professor of neurology, Albert Einstein College of Medicine, discussed recent developments in Alzheimer disease research, including FDA approval of aducanumab, as well as the importance of engaging community-based organizations to improve patient care.
Biogen Head Pens Open Letter Regarding Aducanumab Controversy in Alzheimer
July 23rd 2021Alfred Sandrock, MD, PhD, head of research and development, Biogen, has published an open letter to the Alzheimer community in an attempt to clarify “misinformation and misunderstanding” that has moved “outside the boundaries of legitimate scientific deliberation.”
Changes to Sleep Care Throughout the COVID-19 Pandemic: Michael Thorpy, MD
July 22nd 2021The director of the Sleep-Wake Disorders Center at Montefiore Medical Center discussed the adjustments clinicians and patients with sleep disorders made throughout the pandemic, including the increased use of telemedicine.
Telehealth and Trial Recruitment in Alzheimer Disease: Jessica Zwerling, MD, MS
July 22nd 2021In Alzheimer disease and dementia, Jessica Zwerling, MD, MS, director, Montefiore Hudson Valley Center of Excellence for Alzheimer’s Disease, believes normalizing trial recruitment aids and telehealth to increase participation is another way to ease delivery of care.